Editorial
EBV-related serological biomarkers for nasopharyngeal cancer remain a hot topic
Abstract
The pathogenic role of Epstein-Barr virus (EBV) for the initiation and progression of nasopharyngeal carcinoma (NPC) has been highly investigated since EBV-DNA was identified in an NPC tumor specimen (1).
